Creative Medical Technology Holdings (CELZ) Minority Interest (2025 - 2026)
Creative Medical Technology Holdings (CELZ) posted quarterly Minority Interest of $23360.0 for Q1 2026, up 133.6% quarter-over-quarter from $10000.0 in Q4 2025.
Creative Medical Technology Holdings (CELZ) Minority Interest (2025 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Minority Interest for 2 consecutive years, with $23360.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Minority Interest changed N/A year-over-year to $23360.0; the TTM figure through Mar 2026 stood at $23360.0 (changed N/A YoY), while the FY2025 annual figure was $10000.0, changed N/A from the prior year.
- Minority Interest improved to $23360.0 in Q1 2026 per CELZ's latest filing, from $10000.0 in the prior quarter.
- Across five years, Minority Interest topped out at $23360.0 in Q1 2026 and bottomed at $10000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24,086.00 |
| Mar 31, 2026 | 23,360.00 |
| Dec 31, 2025 | 10,000.00 |